Previous studies have reported that ESM1 could accelerate myeloid leukemia cell 45, BRCA cell 20 and NSCLC cell 17 proliferation, as well as promote the apoptosis escape of CRC cells 46, myeloid leukemia cells 45, and BCA cells 47. Here, ESM1 is linked to non-small cell lung carcinoma.